Please contact our sales representative to learn more information about this reagents.
Background
Onartuzumab is a humanized monoclonal antibody designed for the treatment of advanced non-small-cell lung cancer. Onartuzumab was developed by Genentech, Inc. It is undergoing clinical trials.